GleanMark is free for all of AprilGet free access

REBLOZYL

Registered
Combined Mark
•

Key Information

Serial Number

88822744

Registration Number

6209351

Status

Registered

Ownership

CC

Owner Name

Type: Organization / Corporation

Address

86 Morris Avenue
Summit, NJ 07901

Critical Dates

First Use Date

Nov 8, 2019

Filing Date

Mar 5, 2020

Registration Date

Dec 1, 2020

Mark Descriptions

Goods

Class 5
Pharmaceutical preparations for use in the treatment of anemia, beta thalassemia, blood disease and cancer

Mark Elements

Text Mark
REBLOZYL
Category
Trademark
Standard Characters
No
Color Claim
Yes
Drawing/Image Description

The mark consists of the word "REBLOZYL" in purple with three pink and purple dots to the right of the word.

Color Details

The color(s) purple and pink is/are claimed as a feature of the mark.

Design Search Codes
26.01.15
Circles, exactly three circles
26.01.21
Circles that are totally or partially shaded.
Related Registrations
5321484
6257051
Data source: USPTO TSDR
View on USPTO website

Trademark Timeline

First Use

Nov 8, 2019

Filing Date

Mar 5, 2020

Publication Date

Sep 15, 2020

Registration Date

Dec 1, 2020

USPTO Records

No documents found for this trademark.

AI Assessment

AI-generated analysis of USPTO data for this trademark. WARNING: Content may not be accurate or up to date. Validate all responses.

No summary available

Never miss important updates for this trademark

Get instant alerts when status changes, similar marks are filed, or renewal deadlines approach